Skip to main content

Articles

Practice Management
The Economics of Biosimilars
Stakeholder Perspective
Modeling the Future Economic Impact of Biosimilars’ Entry into the US Market
Read More
Practice Management
The Incidence Rate and Economic Burden of Community-Acquired Pneumonia in a Working-Age Population
Stakeholder Perspective
CAP Is a Burden for All Ages—Prevention Strategies Are Key
Read More
Practice Management
Technological Changes Can Transform Medicine by 2020: A Conversation with the Futurist Jim Carroll
Read More
Diagnosis and Management of Myelofibrosis: Practical Strategies for the Healthcare Team Proceedings from a Multidisciplinary Roundtable
Read More
Intensive Treatment Early in Type 1 Diabetes Produces Substantial Long-Term Benefits
Read More
New Data Show Ranolazine Most Effective Antianginal Agent for Patients with Type 2 Diabetes and HbA1c >7%
Read More
FDA Approvals
Albiglutide, a GLP-1 Receptor Agonist, Effective in Various Treatment Scenarios in Patients with Type 2 Diabetes
Read More
Financial Incentives Can Promote Maintenance of Weight Loss, a Major Factor in Diabetes
Read More
Costs of Diabetes-Related Complications Reduced with Canagliflozin Monotherapy
Read More
Resource Utilization and Costs: Comparing Saxagliptin and Sitagliptin
Read More
Page 165 of 244
Results 1641 - 1650 of 2439